Cryoport Inc (NASDAQ:CYRX)

66.45
Delayed Data
As of Nov 26
 -2.17 / -3.16%
Today’s Change
42.02
Today|||52-Week Range
86.30
+51.44%
Year-to-Date
SECTOR
Transportation
INDUSTRY
Air Freight/Couriers
MARKET CAP
$3.3B

Company Description

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Contact Information

CryoPort, Inc.
112 Westwood Place
Brentwood Tennessee 37027
P:(949) 470-2300
Investor Relations:

Employees

Shareholders

Mutual fund holders58.60%
Individual stakeholders3.18%
Other institutional29.94%

Top Executives

Jerrell W. SheltonChairman, President & Chief Executive Officer
Phil WilsonChief Operating Officer
Robert S. StefanovichChief Financial Officer, Secretary & Treasurer
Bret BollingerChief Technology Officer
Mark W. SawickiChief Scientific Officer